Biopharma
+109
Drug Discovery (2025 Update)
Next-gen biopharma is tackling "undruggable" targets through AI-driven drug discovery, novel protein degradation, and unique modalities like Helicon peptides. Several firms focus on neurodegenerative diseases and oncology.
👋🏼 Hey there! Bounce Watch here — I'm gathering key information from Drug Discovery list.
Real-Time Scouting Assistant
Explore Drug Discovery featuring 116 Companies in Biopharma Industry
|
|
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
Augustine Therapeutics | - | Innovative Therapies for Neuromuscular and Neurodegenerative Disorders | Augustine Therapeutics focuses on the discovery and development of innovative me... | - |
Belgium
|
- | Belgium (HQ) | 2019 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
14
|
750 (443%) | 10 months ago | Series A | 2 | 21.2M | 2760 | 5 months ago | |
|
|
|
TissueLabs | - | The platform for creating organs and tissues in the lab. | The platform for creating organs and tissues in the lab. | - |
Switzerland
|
- | Switzerland (HQ) | 2019 | Biopharma, Biotechnology +3 | [email protected] |
1
Low
|
14
|
1.9K | 1 year ago | Pre Seed | 10 | 1.9M | 14925 | 5 months ago | |
|
|
|
DyNAbind GmbH | - | Accelerating Drug Discovery | DyNAbind is your preferred partner for fast, reliable DNA-Encoded Library drug d... | - |
Germany
|
Dresden | Germany (HQ) | 2017 | Biopharma, Biotechnology | [email protected] |
1
Low
|
8
|
814 | 6 years ago | Seed | 1 | Unknown | 1883 | 7 months ago | |
|
|
|
Captor Therapeutics SA | - | Captor Therapeutics aims to treat cancer, infections, and diseases by targeting... | Captor Therapeutics is a publicly-listed (WSE:CTX) innovative drug discovery and... | - |
Poland
|
- | Poland (HQ) | 2017 | Biopharma, Biotechnology | [email protected] |
1
Low
|
87
|
1.2K | - | - | - | - | 4992 | 5 months ago | |
|
|
|
Wren Therapeutics | - | Stopping the wave of neurodegeneration at its source | WaveBreak (www.WaveBreakTx.com) is a biopharmaceutical company focused transform... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) | 2016 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
34
|
115 (-100%) | 4 years ago | Series Unknown | 3 | 30.4M | 2143 | 1 year ago | |
|
|
|
Arctoris | - | Arctoris is a tech-enabled Contract Research Organization (CRO) headquartered in... | Arctoris is a tech-enabled Partnership Research Organization (PRO) headquartered... | - |
United Kingdom
|
- | United Kingdom (HQ) | 2016 | AI, Automation +5 | [email protected] |
1
Low
|
37
|
1.8K | 5 years ago | Seed | 3 | 10.0M | 6945 | 2 months ago | |
|
|
|
InterAx Biotech | - | Advanced integration of biological systems, math models and artificial intellige... | The company, a spin-out of ETH Zurich and the Paul Scherrer Institute, Switzerla... | - |
Switzerland
|
- | Switzerland (HQ) | 2016 | AI, Biopharma +4 | - |
1
Low
|
17
|
237 (-73%) | 5 years ago | Grant | 8 | 8.0M | 1720 | 5 months ago | |
|
|
|
Turbine | - | We are building the world’s leading predictive simulation of patient biology. | Truly meaningful medicine comes from breakthroughs in deeply understanding patie... | - |
Hungary
|
- | Hungary (HQ) | 2016 | AI, Biopharma +1 | [email protected] |
1
Low
|
103
|
6.3K (5%) | 1 year ago | Series Unknown | 6 | 34.2M | 5765 | 5 months ago | |
|
|
|
Pangea Bio | - | Drug discovery inspired by nature, powered by AI | Pangea develops transformative medicines for neurological disorders, deploying A... | - |
United Kingdom
|
London | United Kingdom (HQ) | 2021 | AI, Biopharma +2 | [email protected] |
1
Low
|
37
|
2.0K | 1 year ago | Seed | 3 | Unknown | 4407 | 2 months ago | |
|
|
|
InFlectis BioScience | Not active anymore | Harnessing expertise in cellular defense and drug discovery to develop molecules... | InFlectis BioScience harnesses its top-tier expertise in the cellular defense sy... | - | - | - | - | 2013 | Biopharma, Biotechnology +2 | [email protected] |
-1
N/A
|
458
|
600 | 1 year ago | Grant | 4 | 10.5M | 993 | 11 months ago | |
|
|
|
Kinomica | - | A proteomic-data science and diagnostics company specialising in cell signalling... | Kinomica is a pioneering precision medicine research and diagnostics company spe... | - |
United Kingdom
|
Alderley Edge | United Kingdom (HQ) + 3 | 2016 | Biopharma, Biotechnology | [email protected] |
1
Low
|
26
|
816 (-100%) | 4 years ago | Series A | 2 | 3.9M | 2187 | 5 months ago | |
|
|
|
FogPharma | - | Until everything is druggable. | FogPharma is developing a new class of drugs to address the limitations of today... | - |
United States
|
Cambridge | United States (HQ) | 2016 | Biopharma, Biotechnology +3 | [email protected] |
1
Low
|
146
|
4.9K (-38%) | 1 year ago | Series E | 6 | 530.3M | 11928 | 6 months ago | |
|
|
|
PMV Pharmaceuticals, Inc. | - | Harnessing the power of p53 to treat cancer | At PMV, we believe that by specifically targeting each mutant p53 we can fundame... | - |
United States
|
Princeton | United States (HQ) | 2013 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
67
|
7.4K (-19%) | 4 years ago | Series D | 4 | 236.0M | 4877 | 4 months ago | |
|
|
|
Advaccine | - | Advancing Vaccines，Improving Immunotherapeutics | Advaccine is an innovative vaccine company with a high-value prophylactic and th... | - |
China
|
- | China (HQ) + 1 | 2009 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
5
|
191 | 4 years ago | Private Equity | 4 | 40.4M | 74 | 5 zSG 7HA | |
|
|
|
DIANA Biotechnologies | - | DIANA Biotechnologies: Diversified Biotech | We are leading Czech biotechnology company with a great innovative potential. We... | - |
Czech Republic
|
- | Czech Republic (HQ) | 2018 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
60
|
3.4K | 7 years ago | Seed | 1 | 3.5M | 3674 | 5 months ago | |
|
|
|
Sevion Therapeutics | Not active anymore | Pioneering groundbreaking therapies for cancer and immunological diseases with i... | Sevion is a biopharmaceutical company focused on discovering, developing, and ac... | - | - | - | - | 1964 | Biopharma, Biotechnology +2 | [email protected] |
-1
N/A
|
811
|
410 | 10 years ago | Post Ipo Equity | 3 | 16.2M | 53643 | 2 ftO Wck | |
|
|
|
PredxBio | - | Reimagining Cancer Care with AI-Driven Spatial Biomarkers | The convergence of unbiased spatial analytics and explainable AI ushers in a new... | - |
United States
|
Pittsburgh | United States (HQ) | 2017 | AI, Biopharma +3 | [email protected] |
1
Low
|
14
|
447 (3%) | 2 years ago | Convertible Note | 9 | 1.7M | 2427 | 4 months ago | |
|
|
|
EOLO PHARMA | - | Cutting-Edge Pharmacological Treatment for Obesity | Drug Discovery company. Developing novel molecules for the treatment of obesity. | - |
United States
|
San Francisco | United States (HQ) | 2017 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
12
|
399 | 2 years ago | Series Unknown | 2 | 4.5M | 982 | 5 months ago | |
|
|
|
ExcepGen | - | Solving fundamental problems in drug discovery to create a new generation of the... | ExcepGen is a venture-backed, early stage biotechnology company located in San F... | - |
United States
|
San Francisco | United States (HQ) | 2018 | Biopharma, Biotechnology +2 | - |
1
Low
|
7
|
226 | 1 year ago | Seed | 3 | 4.2M | 1079 | 1 year ago | |
|
|
|
MapLight Therapeutics, In... | - | Creating breakthrough innovative therapeutics for serious CNS disorders | Maplight is a biopharmaceutical company discovering and developing novel therape... | - |
United States
|
Palo Alto | United States (HQ) + 1 | 2018 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
96
|
2.2K (-27%) | 1 year ago | Series C | 4 | 268.1M | 9691 | 5 months ago |